Cargando…

Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Recently we showed that delta radiomics features (DRF) from daily CT-guided chemoradiation therapy (CRT) is associated with early prediction of treatment response for pancreatic cancer. CA19-9 is a widely used clinical biomarker for pancreatic cancer. The purpose of this work is to investigate if th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasief, Haidy, Hall, William, Zheng, Cheng, Tsai, Susan, Wang, Liang, Erickson, Beth, Li, X. Allen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960122/ https://www.ncbi.nlm.nih.gov/pubmed/31970088 http://dx.doi.org/10.3389/fonc.2019.01464

Ejemplares similares

A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer
por: Nasief, Haidy, et al.
Publicado: (2019)

Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer
por: Wittmann, David, et al.
Publicado: (2020)

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma
por: Krishna, Satheesh, et al.
Publicado: (2023)

Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study
por: Chen, Xiaojian, et al.
Publicado: (2017)

PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study()()
por: Dalah, Entesar, et al.
Publicado: (2018)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
por: Katz, Matthew H. G., et al.
Publicado: (2010)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy
por: Wang, Likun, et al.
Publicado: (2023)

Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study
por: Mao, Yitao, et al.
Publicado: (2022)

Human Pancreatic Cancer-Associated Stellate Cells Remain Activated after in vivo Chemoradiation
por: Cabrera, M. Carla, et al.
Publicado: (2014)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Predictive Value of Delta-Radiomics Texture Features in 0.35 Tesla Magnetic Resonance Setup Images Acquired During Stereotactic Ablative Radiotherapy of Pancreatic Cancer
por: Simpson, Garrett, et al.
Publicado: (2022)

How Does the Delta-Radiomics Better Differentiate Pre-Invasive GGNs From Invasive GGNs?
por: Ma, Yanqing, et al.
Publicado: (2020)

Prediction of Response to Induction Chemotherapy Plus Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma Based on MRI Radiomics and Delta Radiomics: A Two-Center Retrospective Study
por: Xi, Yuzhen, et al.
Publicado: (2022)

Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure
por: Chiloiro, Giuditta, et al.
Publicado: (2020)

CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
por: Li, Jiazheng, et al.
Publicado: (2023)

Delta-radiomics based on CT predicts pathologic complete response in ESCC treated with neoadjuvant immunochemotherapy and surgery
por: Li, Kaiyuan, et al.
Publicado: (2023)

Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation
por: Nelson, Bailey, et al.
Publicado: (2022)

A delta-radiomics model for preoperative prediction of invasive lung adenocarcinomas manifesting as radiological part-solid nodules
por: Chen, Wufei, et al.
Publicado: (2022)

A Nomogram Combined Radiomic and Semantic Features as Imaging Biomarker for Classification of Ovarian Cystadenomas
por: Pan, Shushu, et al.
Publicado: (2020)

Treatment Response Prediction Using Ultrasound-Based Pre-, Post-Early, and Delta Radiomics in Neoadjuvant Chemotherapy in Breast Cancer
por: Yang, Min, et al.
Publicado: (2022)

Value of Pretreatment (18)F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy
por: Barnes, Chad A., et al.
Publicado: (2020)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients
por: Zhong, Ailing, et al.
Publicado: (2019)

CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer
por: Yin, Lingdi, et al.
Publicado: (2022)

Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy
por: Ge, Long, et al.
Publicado: (2017)

Combined CT and serum CA19-9 for stratifying risk for progression in patients with locally advanced pancreatic cancer receiving intraoperative radiotherapy
por: Cai, Wei, et al.
Publicado: (2023)

Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas
por: Permuth, Jennifer B., et al.
Publicado: (2021)

Differential diagnosis of pancreatic cystic neoplasms through a radiomics-assisted system
por: Dong, Zhenglin, et al.
Publicado: (2022)

Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma
por: Ren, Shuai, et al.
Publicado: (2020)

Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
por: Deng, Yan, et al.
Publicado: (2021)

A CT based radiomics nomogram for differentiation between focal-type autoimmune pancreatitis and pancreatic ductal adenocarcinoma
por: Lu, Jia, et al.
Publicado: (2023)

Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review
por: Scirocco, Erica, et al.
Publicado: (2021)

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach
por: Guerrisi, Antonino, et al.
Publicado: (2021)

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer
por: Xu, Rong, et al.
Publicado: (2023)

Response Prediction to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Delta-Radiomics Based on Sequential Whole-Tumor ADC Map
por: An, Dianzheng, et al.
Publicado: (2022)

Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy
por: Xie, Dong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2golabcglr97nagn2rkbald5v